These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 24557813)

  • 1. Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study.
    Starling AP; Engel SM; Richardson DB; Baird DD; Haug LS; Stuebe AM; Klungsøyr K; Harmon Q; Becher G; Thomsen C; Sabaredzovic A; Eggesbø M; Hoppin JA; Travlos GS; Wilson RE; Trogstad LI; Magnus P; Longnecker MP
    Am J Epidemiol; 2014 Apr; 179(7):824-33. PubMed ID: 24557813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
    Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
    Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
    Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
    Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with hypertensive disorders of pregnancy in the Atlanta African American Maternal-Child cohort.
    Thompson M; Eatman JA; Dunlop AL; Barr DB; Kannan K; Corwin EJ; Ryan PB; Panuwet P; Yakimavets V; Taibl KR; Tan Y; Liang D; Eick SM
    Chemosphere; 2024 Jun; 357():142052. PubMed ID: 38631500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menstrual cycle characteristics as determinants of plasma concentrations of perfluoroalkyl substances (PFASs) in the Norwegian Mother and Child Cohort (MoBa study).
    Singer AB; Whitworth KW; Haug LS; Sabaredzovic A; Impinen A; Papadopoulou E; Longnecker MP
    Environ Res; 2018 Oct; 166():78-85. PubMed ID: 29879567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early pregnancy serum levels of perfluoroalkyl substances and risk of preeclampsia in Swedish women.
    Wikström S; Lindh CH; Shu H; Bornehag CG
    Sci Rep; 2019 Jun; 9(1):9179. PubMed ID: 31235847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women.
    Brantsæter AL; Whitworth KW; Ydersbond TA; Haug LS; Haugen M; Knutsen HK; Thomsen C; Meltzer HM; Becher G; Sabaredzovic A; Hoppin JA; Eggesbø M; Longnecker MP
    Environ Int; 2013 Apr; 54():74-84. PubMed ID: 23419425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and the risk of hypertensive disorders of pregnancy.
    Huang R; Chen Q; Zhang L; Luo K; Chen L; Zhao S; Feng L; Zhang J
    Environ Health; 2019 Jan; 18(1):5. PubMed ID: 30626391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants and Temporal Trends of Perfluoroalkyl Substances in Pregnant Women: The Hokkaido Study on Environment and Children's Health.
    Tsai MS; Miyashita C; Araki A; Itoh S; Bamai YA; Goudarzi H; Okada E; Kashino I; Matsuura H; Kishi R
    Int J Environ Res Public Health; 2018 May; 15(5):. PubMed ID: 29758015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between perfluoroalkyl substances and lipid profile in exposed pregnant women in the Veneto region, Italy.
    Dalla Zuanna T; Savitz DA; Barbieri G; Pitter G; Zare Jeddi M; Daprà F; Fabricio ASC; Russo F; Fletcher T; Canova C
    Ecotoxicol Environ Saf; 2021 Feb; 209():111805. PubMed ID: 33360787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Association Between Perfluoroalkyl Substances and Lipids in Cord Blood.
    Spratlen MJ; Perera FP; Lederman SA; Robinson M; Kannan K; Herbstman J; Trasande L
    J Clin Endocrinol Metab; 2020 Jan; 105(1):43-54. PubMed ID: 31536623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women.
    Ren Y; Jin L; Yang F; Liang H; Zhang Z; Du J; Song X; Miao M; Yuan W
    Environ Health; 2020 Aug; 19(1):88. PubMed ID: 32807188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood.
    Granum B; Haug LS; Namork E; Stølevik SB; Thomsen C; Aaberge IS; van Loveren H; Løvik M; Nygaard UC
    J Immunotoxicol; 2013; 10(4):373-9. PubMed ID: 23350954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfluoroalkyl substances and time to pregnancy in couples from Greenland, Poland and Ukraine.
    Jørgensen KT; Specht IO; Lenters V; Bach CC; Rylander L; Jönsson BA; Lindh CH; Giwercman A; Heederik D; Toft G; Bonde JP
    Environ Health; 2014 Dec; 13():116. PubMed ID: 25533644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of perfluoroalkyl substances with gestational hypertension and preeclampsia in the MIREC study.
    Borghese MM; Walker M; Helewa ME; Fraser WD; Arbuckle TE
    Environ Int; 2020 Aug; 141():105789. PubMed ID: 32408216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-Life Exposure to Perfluoroalkyl Substances and Childhood Metabolic Function.
    Fleisch AF; Rifas-Shiman SL; Mora AM; Calafat AM; Ye X; Luttmann-Gibson H; Gillman MW; Oken E; Sagiv SK
    Environ Health Perspect; 2017 Mar; 125(3):481-487. PubMed ID: 27586368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfluoroalkyl Substances during Pregnancy and Offspring Weight and Adiposity at Birth: Examining Mediation by Maternal Fasting Glucose in the Healthy Start Study.
    Starling AP; Adgate JL; Hamman RF; Kechris K; Calafat AM; Ye X; Dabelea D
    Environ Health Perspect; 2017 Jun; 125(6):067016. PubMed ID: 28669937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal exposure to perfluoroalkyl substances and the risk of congenital cerebral palsy in children.
    Liew Z; Ritz B; Bonefeld-Jørgensen EC; Henriksen TB; Nohr EA; Bech BH; Fei C; Bossi R; von Ehrenstein OS; Streja E; Uldall P; Olsen J
    Am J Epidemiol; 2014 Sep; 180(6):574-81. PubMed ID: 25139206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances in pregnant women from a birth cohort in Shanghai, China.
    Tian Y; Zhou Y; Miao M; Wang Z; Yuan W; Liu X; Wang X; Wang Z; Wen S; Liang H
    Environ Int; 2018 Oct; 119():165-173. PubMed ID: 29958117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal serum levels of perfluoroalkyl substances in early pregnancy and offspring birth weight.
    Wikström S; Lin PI; Lindh CH; Shu H; Bornehag CG
    Pediatr Res; 2020 May; 87(6):1093-1099. PubMed ID: 31835271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.